My interpretation of the "Bill Gates" hypothesis is that the "Spike Protein" vaccines don't stop the virus replicating.
But maybe they DO tell the body (in most cases) that it's not necessary to react with a cytokine storm, thus reducing hospitalization and death.
I'm not sure there's a full-virus vaccine in the pipeline. Another $1B, another year?
I see NO reason not to take one of the current crop -- even if I have to take a booster every 6 months or so.
I'll take the 80% reduction in death rates, thank you. (Overall, higher at my age).
ps: Thanks, CDC, for not studying asymptomatic and mild cases.
pps: This is all from memory .. I haven't done any re-research on it.
Edit:
Early clinical trial data in for whole virus COVID-19 vaccine candidate
https://www.news-medical.net/n…19-vaccine-candidate.aspx
In a study uploaded to the preprint server medRxiv*, the efficacy of one such vaccine, termed VLA2001, was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.
[ Note -- Phase 1 - 15 participants in 3 groups ]
Edit 2 :
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in AdultsA Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2780562
Findings This prespecified interim analysis of a randomized clinical trial included 40 382 participants who received at least 1 dose of a 2-dose inactivated vaccine series developed from either SARS-CoV-2 WIV04 (5 µg/dose) or HB02 (4 µg/dose) strains or an aluminum hydroxide–only control, with a primary end point of the incidence of symptomatic COVID-19 at least 14 days after the second injection. The efficacy for the 2 vaccines, compared with an aluminum hydroxide–only control, was 72.8% in the WIV04 group and 78.1% in the HB02 group; both comparisons were statistically significant.